Glycan:glycan interactions: High affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cells
Christopher J. Day,Elizabeth Ngoc Hoa Tran,Evgeny A. Semchenko,Greg Tram,Lauren E. Hartley-Tassell,Preston S. K. Ng,Rebecca M. King,Rachel Ulanovsky,Sarah McAtamney,Michael A. Apicella,Joe Tiralongo,Renato Morona,Victoria Korolik,Michael P. Jennings +13 more
TL;DR: This report shows that the saccharide component of LOS/LPS have direct, high-affinity interactions with host glycans, the first report to the authors' knowledge of high affinity glycan:glycan interactions between bacterial pathogens and the host.
read more
Abstract: Cells from all domains of life express glycan structures attached to lipids and proteins on their surface, called glycoconjugates. Cell-to-cell contact mediated by glycan:glycan interactions have been considered to be low-affinity interactions that precede high-affinity protein–glycan or protein–protein interactions. In several pathogenic bacteria, truncation of surface glycans, lipooligosaccharide (LOS), or lipopolysaccharide (LPS) have been reported to significantly reduce bacterial adherence to host cells. Here, we show that the saccharide component of LOS/LPS have direct, high-affinity interactions with host glycans. Glycan microarrays reveal that LOS/LPS of four distinct bacterial pathogens bind to numerous host glycan structures. Surface plasmon resonance was used to determine the affinity of these interactions and revealed 66 high-affinity host–glycan:bacterial–glycan pairs with equilibrium dissociation constants (KD) ranging between 100 nM and 50 µM. These glycan:glycan affinity values are similar to those reported for lectins or antibodies with glycans. Cell assays demonstrated that glycan:glycan interaction-mediated bacterial adherence could be competitively inhibited by either host cell or bacterial glycans. This is the first report to our knowledge of high affinity glycan:glycan interactions between bacterial pathogens and the host. The discovery of large numbers of glycan:glycan interactions between a diverse range of structures suggests that these interactions may be important in all biological systems.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Structural and functional diversity of neutrophil glycosylation in innate immunity and related disorders.
TL;DR: The building knowledge of the structural and functional diversity displayed by N- and O-linked glycoproteins spatiotemporally expressed and sequentially brought-into-action across the diverse neutrophil life stages during bone marrow maturation and movements to, from and within the blood circulation is summarized.
Protocol to quantify glycan-mediated binding between viral particles and human peripheral blood mononuclear cells using nanoluciferase.
Belinda L. Spillings,Johnson Mak +1 more
TL;DR: A protocol for quantifying the level of glycan-mediated binding between virus or virus-like-particles and human peripheral blood mononuclear cells (PBMCs) using a nanoluciferase reporter system is presented.
A facile method for cellular N-glycomic profiling by matrix-assisted laser desorption/ionization mass spectrometry
TL;DR: An optimized co-derivatization method was applied for convenient, rapid and highly-sensitive analysis of cellular N-glycan, showing great potential for high-throughput analysis of N- glycans from limited cell samples, such as primary cell lines, cells obtained from cell sorting and small size cancer specimens.
References
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
Dag Ilver,Anna Arnqvist,Johan Ögren,Inga-Maria Frick,Dangeruta Kersulyte,Engin T. Incecik,Douglas E. Berg,Antonello Covacci,Lars Engstrand,Thomas Borén +9 more
TL;DR: The bacterial Leb-binding phenotype was associated with the presence of the cag pathogenicity island among clinical isolates of H. pylori, suggesting that a vaccine strategy based on the BabA adhesin might serve as a means to target the virulent type I strains of the bacterium.
1.2K
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation.
Jafar Mahdavi,Berit Sondén,Martina Hurtig,Farzad O. Olfat,Farzad O. Olfat,Lina Forsberg,Niamh Roche,Jonas Ångström,Thomas Larsson,Susann Teneberg,Karl-Anders Karlsson,Siiri Altraja,Torkel Wadström,Dangeruta Kersulyte,Douglas E. Berg,Andre Dubois,Christoffer Petersson,Karl-Eric Magnusson,Thomas Norberg,Frank Lindh,Bertil Lundskog,Anna Arnqvist,Lennart Hammarström,Thomas Borén +23 more
TL;DR: The ability of many H. pylori strains to adhere to sialylated glycoconjugates expressed during chronic inflammation might contribute to virulence and the extraordinary chronicity ofH.pylori infection.
Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection.
Guillermo M. Ruiz-Palacios,Luz Elena Cervantes,Pilar Ramos,Bibiana Chávez-Munguía,David S. Newburg +4 more
TL;DR: It is concluded that campylobacter binding to intestinal H-2 antigen is essential for infection and milk fucosyloligosaccharides and specific fucOSyl α1,2-linked molecules inhibit this binding and may represent a novel class of antimicrobial agents.
636
Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.
Hope B. Tang,Emily DiMango,Ruth Bryan,M Gambello,Barbara H. Iglewski,Joanna B. Goldberg,Alice Prince +6 more
TL;DR: The expression of several P. aeruginosa virulence factors appears to be required to establish pulmonary infection in the neonatal mouse, as might be present in certain pathological conditions.
427
Sodium cyanoborohydride ‐ a highly selective reducing agent for organic functional groups
TL;DR: In this article, die Herstellung, Reinigung, die physikalischen und chemischen Eigenschaften von Natriumcyanoborhydrid sowie dessen Verwendung als selektives Mittel zur Reduktion von Aldehyden, Ketonen, Oximen und Enaminen.
389